SAN FRANCISCO, Aug. 17, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Active ...
Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients Directory" directory has been added to ResearchAndMarkets.com's offering. Published annually the Active Pharmaceutical ...
U.S. Active Pharmaceutical Ingredients (APIs) Market · GlobeNewswire Inc. Dublin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The "United States Active Pharmaceutical Ingredients (APIs) Market - Growth, Trends ...
With a substantial manufacturing base already locked down in China, CRDMO BioDuro is taking a short jaunt down to Taiwan for its latest drug ingredients production play. | BioDuro, headquartered in ...
Active Pharmaceutical Ingredient (API) Market Size, Share & Trends Analysis Report By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Application, By Region, ...
Jan 31 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab will divest its active pharmaceutical ingredient (API) unit to focus on its core business, the world's largest generic drugs ...
SAN FRANCISCO, April 29, 2025 /PRNewswire/ -- The global active pharmaceutical ingredients market size is projected to reach USD 359.45 billion by 2030, and it is expected to exhibit a CAGR of 5.85% ...
It’s official: Two years and one pandemic after Sanofi unveiled plans to spin off its European drug ingredients business, EUROAPI has debuted on the Euronext exchange. Shares in the new active ...
Technological progressions to increase manufacturing capacity in API production offers higher market prospects in developed markets for specialty active pharmaceutical ingredients (API). Substantial ...
DUBLIN--(BUSINESS WIRE)--The "Global Active Pharmaceutical Ingredient Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and ...
TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results